Could this be Jennifer Lawrence’s most controversial role yet?

  • Marie Claire is supported by its audience. When you purchase through links on our site, we may earn commission on some of the items you choose to buy.
  • So, this is exciting

    The race for the Oscars has well and truly started, with Academy award winner and most quotable actress of all time, Jennifer Lawrence, in talks to play Silicon Valley CEO Elizabeth Holmes, Deadline reports.

    The new film, set to be produced by Adam McKay (the man who made adjustable-rate mortgages Oscar-worthy in The Big Short) will document the rise and fall of Elizabeth Holmes, America’s richest self-made woman thanks to her pioneering medical company, Theranos.

    Founded in 2003, Holmes’ biotech company was set to revolutionise the medial landscape with new blood testing system, Edison, which eschewed the traditional practice of extracting blood though a syringe, claiming it could perform a number of tests successfully by using just a pinprick of blood instead.

    Holmes, who owned 50% of the company, was recently ranked by Forbes as America’s richest self-made woman, estimated at a staggering $4.5 billion, however Theranos are now under investigation after allegations that the company’s blood-testing device gave inaccurate results. The fallout of this investigation has now seen Holmes’ net worth plummet to zero.

    Alongside McKay, Jennifer Lawrence is rumoured to be both starring, and producing what will surely be one of the most complex and controversial stories of the year – all it needs now is a studio to back it, which judging by both the subject matter and A-list names attached, we doubt will take long.

    Reading now